Verition Fund Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-24,752
Closed -$15K – 2526
2022
Q1
$15K Buy
+24,752
New +$13.5K ﹤0.01% 2630

Other funds holding DRTSW

Verition Fund Management's DRTSW Position: Q2 2022 in Review

Verition Fund Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2022, closing a stake of 24,752 shares — an estimated $15K sold.

Verition Fund Management first reported a position in DRTSW in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 37 funds tracked by Wall St. Rank hold DRTSW as of Q2 2022.

  • Verition Fund Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • Verition Fund Management sold 24,752 Alpha Tau Medical Warrant shares in Q2 2022, an estimated $15K.
  • Verition Fund Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 1 quarter.
  • Verition Fund Management's Alpha Tau Medical Warrant position peaked at $15K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2022.

Based on Verition Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.